Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Finn Stecher-Rasmussen"'
Autor:
Andrea Wittig, J. Rassow, Finn Stecher-Rasmussen, Ralf A. Hilger, Wolfgang Sauerwein, Pierluigi Mauri
Publikováno v:
Applied Radiation and Isotopes. 69:1760-1764
Boron neutron capture therapy relies on the preferential delivery of a (10)B-compound to tumor cells. The BSH-biodistribution was investigated in nu/nu mice and human patients. The boron concentration was measured with prompt gamma ray spectroscopy.
Publikováno v:
Nuclear Technology. 168:196-201
Generally, the determination of the gamma-ray dose in a mixed neutron-gamma field is obtained by using "neutron-insensitive" detectors. For this purpose, graphite, magnesium, and aluminum ionization chambers are available. It is known that graphite c
Publikováno v:
Nuclear Technology. 168:29-34
The neutron and gamma dose in boron neutron capture therapy (BNCT) can be determined by using ionization chambers of different materials. However, inexplicable results, such as negative doses, are sometimes obtained. Computer simulations using MCNPX
Autor:
Piero A. Salvadori, Wolfgang Sauerwein, Ralf A. Hilger, Jean Michel, Andrea Wittig, Saverio Altieri, Pierluigi Mauri, Peter Bendel, Heinrich F. Arlinghaus, Robert G. Zamenhof, R. Moss, Luca Menichetti, Finn Stecher-Rasmussen
Publikováno v:
Critical reviews in oncology/hematology 68 (2008): 66–90. doi:10.1016/j.critrevonc.2008.03.004
info:cnr-pdr/source/autori:Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA./titolo:Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT)/doi:10.1016%2Fj.critrevonc.2008.03.004/rivista:Critical reviews in oncology%2Fhematology/anno:2008/pagina_da:66/pagina_a:90/intervallo_pagine:66–90/volume:68
info:cnr-pdr/source/autori:Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA./titolo:Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT)/doi:10.1016%2Fj.critrevonc.2008.03.004/rivista:Critical reviews in oncology%2Fhematology/anno:2008/pagina_da:66/pagina_a:90/intervallo_pagine:66–90/volume:68
Boron Neutron Capture Therapy (BNCT) is based on the ability of the stable isotope 10B to capture neutrons, which leads to a nuclear reaction producing an alpha- and a 7Li-particle, both having a high biological effectiveness and a very short range i
Autor:
Andrea Wittig, Finn Stecher-Rasmussen, R. Moss, Klaas Appelman, Antoanetta Roca, Wolfgang Sauerwein, J. Rassow
Publikováno v:
Strahlentherapie und Onkologie. 181:774-782
At the High Flux Reactor (HFR), Petten, The Netherlands, EORTC clinical trials of Boron Neutron Capture Therapy (BNCT) have been in progress since 1997. BNCT involves the irradiation of cancer patients by a beam of neutrons, with an energy range of p
Publikováno v:
Verbakel, WFAR, Sauerwein, W, Hideghety, K & Stecher-Rasmussen, F 2003, ' Boron concentrations in brain during boron neutron capture therapy: In vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope ', International Journal of Radiation Oncology Biology Physics, vol. 55, no. 3, pp. 743-756 . https://doi.org/10.1016/S0360-3016(02)04392-4
International Journal of Radiation Oncology Biology Physics, 55(3), 743-756. Elsevier Inc.
International Journal of Radiation Oncology Biology Physics, 55(3), 743-756. Elsevier Inc.
Purpose: Gamma-ray spectroscopic scans to measure boron concentrations in the irradiated volume were performed during treatment of 5 patients suffering from brain tumors with boron neutron capture therapy (BNCT). In BNCT, the dose that is meant to be
Autor:
Corine Vroegindeweij, Ray Moss, Juergen Rassow, Wim Voorbraak, Finn Stecher-Rasmussen, Katalin Hideghéty, Wolfgang Sauerwein
Publikováno v:
Radiotherapy and Oncology. 59:99-108
The European Council Directive on health protection 97/43/EURATOM requires radiotherapy quality assurance programmes for performance and safety characteristics including acceptance and repeated tests. For Boron Neutron Capture therapy (BNCT) at the H
Autor:
René Huiskamp, Ray Moss, Floyd Wheeler, Finn Stecher-Rasmussen, Corine van Vliet-Vroegindeweij
Publikováno v:
Radiation Research. 155:490-497
Due to the limitations of existing microdosimetry models, a new model called MICOR has been developed to analyze the spatial distribution of microscopic energy deposition for boron neutron capture therapy (BNCT). As in most existing models, the react
Autor:
Klaas Appelman, Wolfgang Sauerwein, R. Moss, Andrea Wittig, Sander Nievaart, Finn Stecher-Rasmussen
Publikováno v:
Applied Radiation and Isotopes. 67:S362-S364
At the boron neutron capture therapy (BNCT) facility in Petten, the Netherlands, (10)B concentrations in biological materials are measured with the prompt gamma ray analyses facility that is calibrated using certified (10)B solutions ranging from 0 t
Autor:
J. Wolbers, Horst Sack, Finn Stecher-Rasmussen, Ray Moss, J. Rassow, Katalin Hideghéty, Wolfgang Sauerwein
Publikováno v:
Strahlentherapie und Onkologie. 175:108-111
Boron Neutron Capture Therapy is based on the ability of the isotope 10B to capture thermal neutrons and to disintegrate instantaneously producing high LET particles. The only neutron beam available in Europe for such a treatment is based at the Euro